Biotech Grw Tst PLC Compliance with Market Abuse Regulation

 
TIDMBIOG 
 
The Biotech Growth Trust PLC ("the Company") 
 
Compliance with Market Abuse Regulation 
 
29 April 2022 
 
The Company confirms that: 
 
a)         all inside information which the Directors and Company may have had 
has been notified to a Regulated Information Service ("RIS"); 
 
b)         the Company's net asset value per share is calculated and announced 
through a RIS on a daily basis; 
 
c)         the Company has no reason to believe that there will be any material 
difference between the net asset value per share as at close of business on 
Thursday 31 March 2022, which was announced on Friday, 1 April 2022, and the 
financial information to be published in the announcement of its results for 
the year ended 31 March 2022. 
 
The Company is, therefore, not prohibited from dealing in its own securities 
during the closed period, as defined by the UK Market Abuse Regulation, which 
will end on the date of the publication of its results for the year ended 31 
March 2022, expected to be on or after Wednesday, 1 June 2022. 
 
                                    -ENDS- 
 
For further information please contact: 
 
Katherine Manson      Frostrow Capital LLP - 020 3 709 8734 
 
 
 
END

(END) Dow Jones Newswires

April 29, 2022 02:00 ET (06:00 GMT)

Biotech Growth (LSE:BIOG)
Historical Stock Chart
From Mar 2024 to Apr 2024